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situation in Sri LankaDear editor,
I read with interest the article on Prostate cancer in Asia
published in the inaugural issue of the Asian Journal of
Urology [1]. The authors should be commended for their
effort in compiling a comprehensive report. A note on the
situation of prostate cancer in Sri Lanka would make it
more complete; hence this letter. Sri Lanka is an island
nation in South Asia situated close to South India with a
population of 20 million. Prostate cancer is the 9th com-
monest cancer among Sri Lankan men [2]. The age
adjusted rate of prostate cancer among men in Sri Lanka is
7.2/100,000 for 2007, which is the latest available data
[2]. This rate is based on data collected by the National
Cancer Control Programme from oncology units of the
country. Therefore some underreporting is expected.
There is no prostate specific antigen (PSA) screening
programme in Sri Lanka although the test is becoming
widely available throughout the country. Facilities for ro-
botic radical prostatectomy are not available in Sri Lanka.
Linear accelerators and tomotherapy machines are avail-
able in few selected centres of the country. Over 90% of
patients requiring androgen deprivation therapy undergo
surgical orchiectomy [3]. Although available, LHRH agonists
are used sparingly due to the high cost. Docetaxel, cab-
azitaxel, and abiraterone are available for the treatment of
castration resistant prostate cancer. Enzalutamide,
sipuleucel-T, and radium 223 are not yet available in
Sri Lanka.
A hospital based study done over 4 years from 2010 to
2013 showed that average age at diagnosis of prostate
cancer in Sri Lanka was 71 years [3]. Over 72% patients had
a serum PSA >20 ng/mL at the time of diagnosis while only
7% had PSA less than 10 ng/mL. Nearly 60% had metastases
at the time of diagnosis. It is interesting to note that 44% of
the patients had a Gleason score of 8 or more. Even after
allowances for lack of PSA screening and delayed presen-
tation there may be an underlying factor hithertohttp://dx.doi.org/10.1016/j.ajur.2015.04.015
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percentage. Furthermore when South Asians migrate to UK
the incidence of prostate cancer increases and the pro-
portion of high grade tumours with a Gleason score over 8
becomes markedly less [4]. These changes were evident
even in the pre-PSA era. Hence it is fair to assume that
there is a dietary or an environmental factor which is
responsible for the low incidence and unusually high rate of
Gleason score over 8 tumours in Sri Lanka e may be an
agent similar to finasteride and dutasteride which also
produce a similar effect.
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